Characterization of SlyA in Shigella flexneri Identifies a Novel Role in Virulence

Infection and Immunity
Natasha Weatherspoon-Griffin, Helen J Wing

Abstract

The SlyA transcriptional regulator has important roles in the virulence and pathogenesis of several members of the Enterobacteriaceae family, including Salmonella enterica serovar Typhimurium and Escherichia coli. Despite the identification of the slyA gene in Shigella flexneri nearly 2 decades ago, as well as the significant conservation of SlyA among enteric bacteria, the role of SlyA in Shigella remains unknown. The genes regulated by SlyA in closely related organisms often are absent from or mutated inS. flexneri, and consequently many described SlyA-dependent phenotypes are not present. By characterizing the expression of slyA and determining its ultimate effect in this highly virulent organism, we postulated that novel SlyA-regulated virulence phenotypes would be identified. In this study, we report the first analysis of SlyA in Shigella and show that (i) the slyA gene is transcribed and ultimately translated into protein, (ii) slyA promoter activity is maximal during stationary phase and is negatively autoregulated and positively regulated by the PhoP response regulator, (iii) the exogenous expression of slyA rescues transcription and virulence-associated deficiencies during virulence-repressed conditions, and (iv) the a...Continue Reading

References

Feb 1, 1990·Journal of Bacteriology·J W Foster, H K Hall
Jun 1, 1989·The Journal of Infectious Diseases·H L DuPontS B Formal
Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A T Maurelli, P J Sansonetti
Jan 1, 1972·Molecular & General Genetics : MGG·F B HaugliA Jimenez
Jan 1, 1972·Molecular & General Genetics : MGG·R C Gethmann
Jan 1, 1984·Infection and Immunity·A T MaurelliR Curtiss
Jan 18, 1994·Proceedings of the National Academy of Sciences of the United States of America·S J LibbyF Heffron
Aug 1, 1993·The Journal of Infectious Diseases·S P CohenS B Levy
Jan 1, 1993·Infection and Immunity·J Gorden, P L Small
Apr 1, 1996·Molecular Microbiology·J OscarssonD J Haydon
Feb 12, 1998·Molecular & General Genetics : MGG·M E Porter, C J Dorman
Jun 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·K A Datsenko, B L Wanner
Feb 27, 2001·Journal of Bacteriology·E A Groisman
May 31, 2003·Journal of Bacteriology·Valia A NorteJeffrey Green
Nov 7, 2003·Nucleic Acids Research·Beatriz GalánMaría A Prieto
Mar 5, 2004·Journal of Bacteriology·Neil R WybornJeffrey Green
Feb 11, 2005·Proceedings of the National Academy of Sciences of the United States of America·Igor ZwirEduardo A Groisman
May 11, 2005·Journal of Molecular Evolution·Pieter MonsieursKathleen Marchal
Mar 15, 2006·Current Opinion in Microbiology·Damon W Ellison, Virginia L Miller

❮ Previous
Next ❯

Citations

Jan 29, 2019·Frontiers in Microbiology·Ritika ChatterjeeDipshikha Chakravortty

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.